Hospital
North Houston - TRMC, LLC
North Houston - TRMC, LLC was paid $4.14M by Medicaid between Feb 2020 and Dec 2024, across 46 billing codes. Its largest line is 99283, emergency room visit (moderate) — 56% of everything it billed.
33Billing provider infoNORTH HOUSTON - TRMC, LLC
TOMBALL, TX 77375
TOMBALL, TX 77375
33aNPI1750819025assigned 05/31/2017
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.14M
24GClaims49,181
24DCodes billed46
24AFirst – last monthFeb 2020 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#38 of 109
Median peer was paid$1.15M
This provider vs. median3.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 511 | $60K | |
| 2021 | 11,520 | $1.15M | |
| 2022 | 15,702 | $1.28M | |
| 2023 | 15,483 | $1.25M | |
| 2024incomplete | 5,965 | $400K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 56% | 15,674 | 15,073 | $2.30M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 33% | 6,044 | 5,354 | $1.37M |
| 87501 | 1.6% | 1,635 | 1,610 | $67K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.5% | 1,553 | 1,525 | $62K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 1,904 | 1,849 | $60K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 336 | 331 | $40K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,525 | 1,376 | $32K |
| 87430 | <1% | 1,832 | 1,787 | $26K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 280 | 273 | $24K |
| 85027 | <1% | 5,666 | 5,100 | $23K | |
| 71045 | Radiologic examination, chest; single view | <1% | 807 | 760 | $22K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,656 | 1,612 | $21K |
34 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 618 | $18K |
| 80053 | Comprehensive metabolic panel | <1% | 1,475 | $17K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,531 | $16K |
| 99285 | Emergency room visit (most serious) | <1% | 153 | $8K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 52 | $8K |
| 81001 | <1% | 1,438 | $4K | |
| 81003 | <1% | 2,020 | $4K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 497 | $3K |
| 76801 | <1% | 27 | $3K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 47 | $2K |
| 80076 | <1% | 259 | $1K | |
| 83690 | <1% | 419 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 14 | $1K |
| 84703 | <1% | 238 | $1K | |
| 81025 | <1% | 166 | $1K | |
| 84484 | <1% | 341 | $674.13 | |
| 86403 | <1% | 76 | $653.05 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 75 | $599.00 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 30 | $596.54 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 43 | $572.50 |
| 82248 | <1% | 222 | $348.56 | |
| 86308 | <1% | 57 | $187.75 | |
| 83880 | <1% | 13 | $164.90 | |
| 84702 | <1% | 15 | $151.68 | |
| 86901 | <1% | 32 | $45.43 | |
| 86900 | <1% | 32 | $45.43 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 46 | $42.46 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14 | $40.68 |
| 85610 | <1% | 31 | $18.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 14 | $4.76 |
| A9270 | Non-covered item or service | 0% | 197 | $0.00 |
| J3490 | Unclassified drugs | 0% | 28 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 12 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 37 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialERVIN, RICHARD (CFO)